Ireland has officially banned hexahydrocannabinol (HHC), a highly addictive cannabis substitute that has been widely available in vapes, edibles, and other products across the country.
The Cabinet decision on Tuesday makes the import, export, production, possession, sale, or supply of HHC products illegal, giving gardaí enhanced enforcement powers under the Misuse of Drugs Act 1977.
HHC, a semi-synthetic cannabinoid with cannabis-like effects, has been linked to serious medical episodes since its first detection in Ireland in 2022. The substance has caused numerous incidents of psychosis and hospitalizations among young people, including a notable case in North Cork where four teenagers required hospital treatment after consuming HHC products.
Health Minister Jennifer Carroll MacNeill brought the proposal to Cabinet after concerns mounted about the drug’s impact on youth mental health. Recent studies show HHC was the second most common drug among patients presenting with psychosis at University Hospital Galway over a 21-month period.
Addiction experts welcome the ban but warn that enforcement will be crucial as the trade may move underground. The classification includes 13 other dangerous substances identified by EU and UN authorities as serious public health risks.
Youth workers emphasize the need for continued vigilance as new synthetic drugs emerge in the marketplace.